ArticleJournal of clinical medicine2026

Hepatotoxicity Risk of Isoniazid in Patients with Autoimmune Rheumatic Diseases and Prior Liver Injury Due to Disease-Modifying Antirheumatic Drugs: A Single-Center Experience and Literature Review.

Joy Selene Osorio-Chávez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.